Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial
et al., Indian Journal of Rheumatology, doi:10.4103/injr.injr_264_21, NCT04867226, May 2022
Colchicine for COVID-19
5th treatment shown to reduce risk in
September 2020, now with p = 0.00000015 from 57 studies.
No treatment is 100% effective. Protocols
combine treatments.
6,200+ studies for
200+ treatments. c19early.org
|
Open label RCT of colchicine showing improved recovery with treatment. Only the abstract is currently available. Colchicine 0.5mg bid for 14 days.
This study is excluded in the after exclusion results of meta
analysis:
minimal details provided.
|
hospitalization time, 24.1% lower, relative time 0.76, p = 0.009, treatment 36, control 44.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Jalal et al., 5 May 2022, Randomized Controlled Trial, Iraq, peer-reviewed, 3 authors, study period 8 May, 2021 - 18 June, 2021, trial NCT04867226 (history).
DOI record:
{
"DOI": "10.4103/injr.injr_264_21",
"ISSN": [
"0973-3698"
],
"URL": "http://dx.doi.org/10.4103/injr.injr_264_21",
"alternative-id": [
"344591"
],
"author": [
{
"affiliation": [],
"family": "Jalal",
"given": "AryanMohamadfatih",
"sequence": "first"
},
{
"affiliation": [],
"family": "Aref",
"given": "SheelanFaroz",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Albustany",
"given": "DashtyAbbas",
"sequence": "additional"
}
],
"container-title": "Indian Journal of Rheumatology",
"container-title-short": "Indian J Rheumatol",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
5,
3
]
],
"date-time": "2022-05-03T03:21:24Z",
"timestamp": 1651548084000
},
"deposited": {
"date-parts": [
[
2022,
5,
3
]
],
"date-time": "2022-05-03T03:22:20Z",
"timestamp": 1651548140000
},
"indexed": {
"date-parts": [
[
2022,
5,
4
]
],
"date-time": "2022-05-04T13:15:53Z",
"timestamp": 1651670153419
},
"is-referenced-by-count": 0,
"issue": "0",
"issued": {
"date-parts": [
[
2022
]
]
},
"journal-issue": {
"issue": "0",
"published-print": {
"date-parts": [
[
2022
]
]
}
},
"language": "en",
"member": "2581",
"original-title": [],
"page": "0",
"prefix": "10.4103",
"published": {
"date-parts": [
[
2022
]
]
},
"published-print": {
"date-parts": [
[
2022
]
]
},
"publisher": "Medknow",
"reference-count": 20,
"references-count": 20,
"relation": {},
"resource": {
"primary": {
"URL": "http://www.indianjrheumatol.com/preprintarticle.asp?id=344591;type=0"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Rheumatology"
],
"subtitle": [],
"title": "Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial",
"type": "journal-article",
"volume": "0"
}
Late treatment
is less effective
is less effective
